Personalized prostate MRI protocol: Selective contrast enhancement for PI-RADS 3 lesions to optimize diagnostic accuracy and resource utilization
Acta Radiologica · 19.11.2026
DOI: 10.1177/02841851261508752 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Acta Radiologica, online erschienen am 19.11.2026. Verfasst von İsmail Özgül und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
The operational burden on radiology departments worldwide has intensified the need for efficient imaging protocols.
Purpose
To compare the efficacies of biparametric magnetic resonance imaging (bpMRI) and multiparametric MRI (mpMRI) in detecting prostate cancer in terms of diagnostic accuracy, acquisition time, and cost, and to propose a personalized imaging protocol with selective contrast medium administration for prostate imaging reporting and data system (PI-RADS) 3 lesions. Material and Methods This study's sample consisted of 1004 patients who underwent prostate mpMRI between 2017 and 2023. Two independent radiologists evaluated cases that underwent bpMRI (T2/DWI) and then mpMRI, per PI-RADS v2.1 guidelines. Inter-protocol agreement was assessed using Cohen's Kappa coefficients. Cost and budget impact analysis was used to compare the methods in terms of cost, acquisition time, and number needed to scan (NNS) to detect one additional malignancy.
Results
Inter-protocol agreement between bpMRI and mpMRI was excellent (κ = 0.951, 95% confidence interval (CI) 0.933–0.969; P < 0.001). The malignancy rate among lesions upgraded from PI-RADS 3 on bpMRI to PI-RADS 4 on mpMRI was significantly higher compared to lesions remaining PI-RADS 3 (66.7% (18/27), 95% CI 47.8–81.4 vs. 19.4% [13/67], 95% CI 11.7–30.4; P < 0.001). Conclusion bpMRI demonstrated high diagnostic performance for detecting prostate cancer, particularly for PI-RADS 1, 2, and 5 lesions. A personalized triage strategy—reserving dynamic contrast enhancement selectively for lesions initially categorized as PI-RADS 3 on bpMRI—offers a pragmatic balance. Rather than an absolute optimal strategy, this approach achieves the higher sensitivity of mpMRI while significantly optimizing acquisition time and costs, accompanied by a recognized and acceptable trade-off in specificity.
Zitieren
APA
Özgül, İ., Keven, A., Gürbüz, A. F., & Çubuk, S. M. (2026). Personalized prostate MRI protocol: Selective contrast enhancement for PI-RADS 3 lesions to optimize diagnostic accuracy and resource utilization. Acta Radiologica. https://doi.org/10.1177/02841851261508752
Vancouver
Özgül İ, Keven A, Gürbüz AF, Çubuk SM. Personalized prostate MRI protocol: Selective contrast enhancement for PI-RADS 3 lesions to optimize diagnostic accuracy and resource utilization. Acta Radiologica. 2026. doi:10.1177/02841851261508752
BibTeX
@article{zgl2026,
author = {Özgül, İsmail and Keven, Ayşe and Gürbüz, Ahmet Faruk and Çubuk, Süleyman Metin},
title = {Personalized prostate MRI protocol: Selective contrast enhancement for PI-RADS 3 lesions to optimize diagnostic accuracy and resource utilization},
journal = {Acta Radiologica},
year = {2026},
doi = {10.1177/02841851261508752}
}
EUVIMED